Table of Contents
Chapter 1. Patient Adoption of Auto-Injectors by Overall Usage and Medication Type
1.1. Market Overview
1.2. A list of auto-injector devices for administering various drugs
1.3. Innovations influencing the adoption of auto-injectors
1.3.1. Two-step, button-free activation
1.3.2. Visual and audible feedback systems
1.3.3. Connectivity & smart features (Bluetooth)
1.3.4. Viscosity-handling for biologics
1.3.5. On-body injectors (wearable auto-injectors)
1.3.6. Pre-filled, pre-assembled devices
1.4. Modality Scope
1.4.1. Epinephrine auto-injectors
1.4.2. Insulin auto-injectors
1.4.3. Disease-modifying therapies (DMTS) for multiple sclerosis
1.4.4. Rheumatoid arthritis medications
1.4.5. GLP-1 weight loss drug auto-injectors
1.4.6. Other medications
1.5. Country Scope
1.5.1. U.S.
1.5.1.1. Total Number of Patients that use Auto-Injectors by Medication Type, U.S., 2018 - 2030
1.5.2. Canada
1.5.2.1. Total Number of Patients that use Auto-Injectors by Medication Type, Canada, 2018 - 2030
1.5.3. UK
1.5.3.1. Total Number of Patients that use Auto-Injectors by Medication Type, UK, 2018 - 2030
1.5.4. Germany
1.5.4.1. Total Number of Patients that use Auto-Injectors by Medication Type, Germany, 2018 - 2030
1.5.5. France
1.5.5.1. Total Number of Patients that use Auto-Injectors by Medication Type, France, 2018 - 2030
1.5.6. Italy
1.5.6.1. Total Number of Patients that use Auto-Injectors by Medication Type, Italy, 2018 - 2030
1.5.7. Spain
1.5.7.1. Total Number of Patients that use Auto-Injectors by Medication Type, Spain, 2018 - 2030
1.5.8. Japan
1.5.8.1. Total Number of Patients that use Auto-Injectors by Medication Type, Japan, 2018 - 2030
1.5.9. China
1.5.9.1. Total Number of Patients that use Auto-Injectors by Medication Type, China, 2018 - 2030
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPA norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.